annual accounts payable:
$4.59M+$2.62M(+133.55%)Summary
- As of today (May 29, 2025), SUPN annual accounts payable is $4.59 million, with the most recent change of +$2.62 million (+133.55%) on December 31, 2024.
- During the last 3 years, SUPN annual accounts payable has fallen by -$4.74 million (-50.84%).
- SUPN annual accounts payable is now -61.00% below its all-time high of $11.76 million, reached on December 31, 2011.
Performance
SUPN Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$7.07M+$2.48M(+54.17%)Summary
- As of today (May 29, 2025), SUPN quarterly accounts payable is $7.07 million, with the most recent change of +$2.48 million (+54.17%) on March 31, 2025.
- Over the past year, SUPN quarterly accounts payable has dropped by -$7.33 million (-50.88%).
- SUPN quarterly accounts payable is now -80.09% below its all-time high of $35.52 million, reached on June 30, 2022.
Performance
SUPN quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
SUPN Accounts payable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +133.6% | -50.9% |
3 y3 years | -50.8% | -42.6% |
5 y5 years | -54.8% | +126.4% |
SUPN Accounts payable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -56.5% | +133.6% | -80.1% | +260.1% |
5 y | 5-year | -56.5% | +133.6% | -80.1% | +260.1% |
alltime | all time | -61.0% | +146.2% | -80.1% | +723.3% |
SUPN Accounts payable History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $7.07M(+54.2%) |
Dec 2024 | $4.59M(+133.6%) | $4.59M(-28.2%) |
Sep 2024 | - | $6.39M(+38.1%) |
Jun 2024 | - | $4.63M(-67.9%) |
Mar 2024 | - | $14.40M(+633.0%) |
Dec 2023 | $1.96M(-81.4%) | $1.96M(-42.0%) |
Sep 2023 | - | $3.39M(-23.0%) |
Jun 2023 | - | $4.40M(-61.9%) |
Mar 2023 | - | $11.54M(+9.5%) |
Dec 2022 | $10.54M(+13.0%) | $10.54M(-34.2%) |
Sep 2022 | - | $16.02M(-54.9%) |
Jun 2022 | - | $35.52M(+188.2%) |
Mar 2022 | - | $12.32M(+32.1%) |
Dec 2021 | $9.33M(+51.8%) | $9.33M(+2.3%) |
Sep 2021 | - | $9.13M(+26.2%) |
Jun 2021 | - | $7.23M(+21.4%) |
Mar 2021 | - | $5.95M(-3.1%) |
Dec 2020 | $6.15M(-39.4%) | $6.15M(-45.1%) |
Sep 2020 | - | $11.19M(+103.0%) |
Jun 2020 | - | $5.51M(+76.5%) |
Mar 2020 | - | $3.12M(-69.2%) |
Dec 2019 | $10.14M(+217.4%) | $10.14M(+228.2%) |
Sep 2019 | - | $3.09M(-24.3%) |
Jun 2019 | - | $4.08M(-43.6%) |
Mar 2019 | - | $7.24M(+126.6%) |
Dec 2018 | $3.19M(-53.3%) | $3.19M(-67.5%) |
Sep 2018 | - | $9.84M(+234.3%) |
Jun 2018 | - | $2.94M(-11.7%) |
Mar 2018 | - | $3.33M(-51.3%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2017 | $6.84M(-15.0%) | $6.84M(+9.3%) |
Sep 2017 | - | $6.26M(-17.4%) |
Jun 2017 | - | $7.58M(+49.9%) |
Mar 2017 | - | $5.06M(-37.2%) |
Dec 2016 | $8.05M(+86.7%) | $8.05M(+200.0%) |
Sep 2016 | - | $2.69M(+19.7%) |
Jun 2016 | - | $2.24M(-15.2%) |
Mar 2016 | - | $2.65M(-38.7%) |
Dec 2015 | $4.31M(+131.6%) | $4.31M(+53.4%) |
Sep 2015 | - | $2.81M(-37.8%) |
Jun 2015 | - | $4.52M(+426.0%) |
Mar 2015 | - | $859.00K(-53.9%) |
Dec 2014 | $1.86M(-40.7%) | $1.86M(-91.5%) |
Sep 2014 | - | $21.98M(+15.4%) |
Jun 2014 | - | $19.04M(+29.9%) |
Mar 2014 | - | $14.66M(+366.5%) |
Dec 2013 | $3.14M(-70.5%) | $3.14M(-78.3%) |
Sep 2013 | - | $14.47M(+23.4%) |
Jun 2013 | - | $11.73M(+7.6%) |
Mar 2013 | - | $10.90M(+2.2%) |
Dec 2012 | $10.67M(-9.3%) | $10.67M(+1.7%) |
Sep 2012 | - | $10.48M(+14.3%) |
Jun 2012 | - | $9.18M(-1.7%) |
Mar 2012 | - | $9.34M(-20.6%) |
Dec 2011 | $11.76M(+4.4%) | $11.76M(+28.6%) |
Sep 2011 | - | $9.15M(-18.8%) |
Dec 2010 | $11.26M(+80.4%) | $11.26M(-20.1%) |
Sep 2010 | - | $14.09M(+125.7%) |
Dec 2009 | $6.25M(+39.8%) | $6.25M |
Dec 2008 | $4.47M | - |
FAQ
- What is Supernus Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals annual accounts payable year-on-year change?
- What is Supernus Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals quarterly accounts payable year-on-year change?
What is Supernus Pharmaceuticals annual accounts payable?
The current annual accounts payable of SUPN is $4.59M
What is the all time high annual accounts payable for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high annual accounts payable is $11.76M
What is Supernus Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, SUPN annual accounts payable has changed by +$2.62M (+133.55%)
What is Supernus Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of SUPN is $7.07M
What is the all time high quarterly accounts payable for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high quarterly accounts payable is $35.52M
What is Supernus Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, SUPN quarterly accounts payable has changed by -$7.33M (-50.88%)